• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性肝炎患儿中程序性死亡-1(PD-1)及其配体PD-L1的肝脏表达:与治疗反应的关系

Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response.

作者信息

Agina Hala A, Ehsan Nermine A, Abd-Elaziz Taghreed A, Abd-Elfatah Ghada A, Said Eman M, Sira Mostafa M

机构信息

Pathology Department, Faculty of Medicine, Benha University, Egypt.

Pathology Department, National Liver Institute, Menoufia University, Egypt.

出版信息

Clin Exp Hepatol. 2019 Sep;5(3):256-264. doi: 10.5114/ceh.2019.87642. Epub 2019 Sep 5.

DOI:10.5114/ceh.2019.87642
PMID:31598564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6781821/
Abstract

AIM OF THE STUDY

Autoimmune hepatitis (AIH) is characterized histologically by aggressive inflammation with interface hepatitis and prominent lymphoplasmacytic infiltration. Programmed death-1 (PD-1) is expressed on activated lymphocytes. Engagement of PD-1 by its ligand PD-L1 leads to cell apoptosis and death. We aimed to evaluate the immunohistochemical expression of PD-1 and PD-L1 in children with AIH, and its relation to treatment outcome.

MATERIAL AND METHODS

Pre-treatment liver biopsies of 31 children with AIH were compared to 30 children with chronic hepatitis C virus (HCV) infection as a control group. PD-1 was evaluated in lymphocytes, while PD-L1 was evaluated in lymphocytes, hepatocytes, biliary epithelial cells, sinusoidal endothelial cells and Kupffer cells. All AIH patients received the standard treatment.

RESULTS

The mean PD-1 was significantly higher in AIH than HCV patients (29.19 ±18.5% vs. 15.2 ±10.1%; = 0.002) while there was no statistically significant difference as regards PD-L1 on lymphocytes ( = 0.853). Neither PD-1 nor PD-L1 correlated with either liver fibrosis or the inflammatory activity ( > 0.05 for all). PD-1/PD-L1 ratio was significantly higher in AIH compared to HCV patients and in non-responder AIH patients compared to responders (46.9 vs. 6.58). PD-1 expression was comparable in both responders and non-responders ( = 0.813), while PD-L1 was significantly upregulated in responders (4.17 ±3.15% vs. 0.63 ±1.3%; = 0.046). PD-L1 expression on hepatocytes, biliary epithelial cells, sinusoidal endothelial cells and Kupffer cells was comparable in AIH and HCV groups.

CONCLUSIONS

PD-1/PD-L1 ratio, which reflects immune aggression, was significantly higher in AIH compared to HCV patients and in non-responder AIH patients compared to responders.

摘要

研究目的

自身免疫性肝炎(AIH)在组织学上的特征为伴有界面性肝炎的侵袭性炎症和显著的淋巴浆细胞浸润。程序性死亡蛋白1(PD-1)在活化淋巴细胞上表达。PD-1与其配体PD-L1结合会导致细胞凋亡和死亡。我们旨在评估AIH患儿中PD-1和PD-L1的免疫组化表达及其与治疗结果的关系。

材料与方法

将31例AIH患儿的治疗前肝活检与30例慢性丙型肝炎病毒(HCV)感染患儿作为对照组进行比较。在淋巴细胞中评估PD-1,而在淋巴细胞、肝细胞、胆管上皮细胞、窦状内皮细胞和库普弗细胞中评估PD-L1。所有AIH患者均接受标准治疗。

结果

AIH患者的平均PD-1显著高于HCV患者(29.19±18.5%对15.2±10.1%;P = 0.002),而淋巴细胞上的PD-L1无统计学显著差异(P = 0.853)。PD-1和PD-L1均与肝纤维化或炎症活动无关(所有P>0.05)。与HCV患者相比,AIH患者以及与反应者相比,无反应的AIH患者的PD-1/PD-L1比值显著更高(46.9对6.58)。反应者和无反应者的PD-1表达相当(P = 0.813),而反应者的PD-L1显著上调(4.17±3.15%对0.63±1.3%;P = 0.046)。AIH组和HCV组中肝细胞、胆管上皮细胞、窦状内皮细胞和库普弗细胞上的PD-L1表达相当。

结论

反映免疫侵袭的PD-1/PD-L1比值在AIH患者中显著高于HCV患者,在无反应的AIH患者中显著高于反应者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce8/6781821/0d4225cfc800/CEH-5-37559-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce8/6781821/8b8a92bf410b/CEH-5-37559-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce8/6781821/579bb7fb294b/CEH-5-37559-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce8/6781821/0d4225cfc800/CEH-5-37559-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce8/6781821/8b8a92bf410b/CEH-5-37559-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce8/6781821/579bb7fb294b/CEH-5-37559-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce8/6781821/0d4225cfc800/CEH-5-37559-g003.jpg

相似文献

1
Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response.自身免疫性肝炎患儿中程序性死亡-1(PD-1)及其配体PD-L1的肝脏表达:与治疗反应的关系
Clin Exp Hepatol. 2019 Sep;5(3):256-264. doi: 10.5114/ceh.2019.87642. Epub 2019 Sep 5.
2
Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis.可溶性程序性死亡-1水平与自身免疫性肝炎患者的疾病活动度及治疗反应相关。
Scand J Gastroenterol. 2017 Jan;52(1):93-99. doi: 10.1080/00365521.2016.1233576. Epub 2016 Sep 23.
3
Kupffer Cell Hyaline Globules in Children With Autoimmune Hepatitis.自身免疫性肝炎患儿的库普弗细胞透明小球
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):20-28. doi: 10.1016/j.jceh.2021.04.013. Epub 2021 May 4.
4
[Effect of antiviral treatment on expression of programmed death 1 and programmed death ligand 1 on peripheral T lymphocytes in patients with chronic hepatitis C].[抗病毒治疗对慢性丙型肝炎患者外周血T淋巴细胞程序性死亡蛋白1及程序性死亡配体1表达的影响]
Zhonghua Gan Zang Bing Za Zhi. 2013 Apr;21(4):261-6. doi: 10.3760/cma.j.issn.1007-3418.2013.04.006.
5
[Association between high expression of intrahepatic programmed death-1 and liver inflammation in patients with autoimmune hepatitis].[自身免疫性肝炎患者肝内程序性死亡蛋白-1高表达与肝脏炎症的关系]
Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):263-267. doi: 10.3760/cma.j.issn.1007-3418.2017.04.006.
6
Intrahepatic PD-1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection.慢性乙型肝炎病毒感染者肝内 PD-1/PD-L1 的上调与炎症和病毒复制密切相关。
Immunol Invest. 2009;38(7):624-38. doi: 10.1080/08820130903062210.
7
Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.共刺激分子程序性死亡-1及其配体在自身免疫性肝病中的肝内表达。
Pathol Int. 2007 Aug;57(8):485-92. doi: 10.1111/j.1440-1827.2007.02129.x.
8
Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice.程序性死亡 1 及其配体在自身免疫性肝炎 C57BL/6 小鼠肝脏中的表达。
Chin Med J (Engl). 2009 Aug 20;122(16):1941-6.
9
Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B.程序性死亡 1 和程序性死亡配体 1 在慢性乙型肝炎患者中的表达。
Hepatobiliary Pancreat Dis Int. 2013 Aug;12(4):394-9. doi: 10.1016/s1499-3872(13)60061-2.
10
Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease.可溶性 PD1 水平在儿科自身免疫性肝炎和炎症性肠病的疾病活动期升高。
Autoimmunity. 2020 Aug;53(5):253-260. doi: 10.1080/08916934.2020.1755964. Epub 2020 May 6.

引用本文的文献

1
AAV-mediated co-expression of an immunogenic transgene plus PD-L1 enables sustained expression through immunological evasion.腺相关病毒介导的免疫原性转基因与 PD-L1 的共表达通过免疫逃逸实现持续表达。
Sci Rep. 2024 Nov 21;14(1):28853. doi: 10.1038/s41598-024-75698-2.
2
Mechanisms of immune checkpoint inhibitor-mediated liver injury.免疫检查点抑制剂介导的肝损伤机制。
Acta Pharm Sin B. 2021 Dec;11(12):3727-3739. doi: 10.1016/j.apsb.2021.10.003. Epub 2021 Oct 16.
3
Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease.

本文引用的文献

1
The efficacy and safety of anti-PD-1/PD-L1 antibody therapy versus docetaxel for pretreated advanced NSCLC: a meta-analysis.抗PD-1/PD-L1抗体疗法与多西他赛用于经治晚期非小细胞肺癌的疗效和安全性:一项荟萃分析。
Oncotarget. 2017 Dec 15;9(3):4239-4248. doi: 10.18632/oncotarget.23279. eCollection 2018 Jan 9.
2
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.纳武利尤单抗治疗晚期肝细胞癌患者(CheckMate 040):一项开放标签、非对照、1/2 期剂量递增和扩展试验。
Lancet. 2017 Jun 24;389(10088):2492-2502. doi: 10.1016/S0140-6736(17)31046-2. Epub 2017 Apr 20.
3
自身免疫性肝病中免疫检查点分子的肝内表达增加。
Cells. 2021 Oct 6;10(10):2671. doi: 10.3390/cells10102671.
4
Deciphering the Dynamic Complexities of the Liver Microenvironment - Toward a Better Understanding of Immune-Mediated liver Injury Caused by Immune Checkpoint Inhibitors (ILICI).解析肝脏微环境的动态复杂性——深入了解免疫检查点抑制剂(ICI)引起的免疫介导性肝损伤。
AAPS J. 2021 Aug 16;23(5):99. doi: 10.1208/s12248-021-00629-2.
5
Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.程序性细胞死亡 1 (PDCD1) 基因单倍型与基底细胞癌患者易感性的关系。
Mol Biol Rep. 2021 Mar;48(3):2047-2052. doi: 10.1007/s11033-020-06115-w. Epub 2021 Jan 3.
6
IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.IL-17A/F 通过上调 PD-L1 表达使胆管细胞能够限制 T 细胞驱动的实验性胆管炎。
J Hepatol. 2021 Apr;74(4):919-930. doi: 10.1016/j.jhep.2020.10.035. Epub 2020 Nov 13.
7
PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response.IFN-α/γ 介导的 Stat1 上调抑制抗 HBV T 细胞反应。
PLoS One. 2020 Jul 6;15(7):e0228302. doi: 10.1371/journal.pone.0228302. eCollection 2020.
Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
针对共抑制性程序性死亡受体1(PD-1)的血清自身抗体水平升高,可促进新发系统性红斑狼疮患者的T细胞增殖,并与疾病活动度相关。
Arthritis Res Ther. 2017 Mar 9;19(1):52. doi: 10.1186/s13075-017-1258-4.
4
Induction of PD-L1 expression by epidermal growth factor receptor-mediated signaling in esophageal squamous cell carcinoma.表皮生长因子受体介导的信号传导在食管鳞状细胞癌中诱导程序性死亡受体配体1(PD-L1)表达
Onco Targets Ther. 2017 Feb 13;10:763-771. doi: 10.2147/OTT.S118982. eCollection 2017.
5
Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis.可溶性程序性死亡-1水平与自身免疫性肝炎患者的疾病活动度及治疗反应相关。
Scand J Gastroenterol. 2017 Jan;52(1):93-99. doi: 10.1080/00365521.2016.1233576. Epub 2016 Sep 23.
6
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.程序性死亡配体 1 在肝细胞癌中的表达:与临床和病理特征的关系。
Hepatology. 2016 Dec;64(6):2038-2046. doi: 10.1002/hep.28710. Epub 2016 Aug 9.
7
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.帕博利珠单抗治疗晚期黑色素瘤患者的肿瘤应答与生存关系。
JAMA. 2016 Apr 19;315(15):1600-9. doi: 10.1001/jama.2016.4059.
8
Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells.传统和非传统抗原呈递细胞及调节性免疫细胞对肝脏耐受性的调节
Cell Mol Immunol. 2016 May;13(3):277-92. doi: 10.1038/cmi.2015.112. Epub 2016 Apr 4.
9
Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes.导致1型糖尿病的抗程序性死亡蛋白1和抗程序性死亡配体1单克隆抗体
Diabetes Care. 2015 Sep;38(9):e137-8. doi: 10.2337/dc15-0889. Epub 2015 Jun 26.
10
Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy.地塞米松在T细胞活化过程中增强程序性细胞死亡蛋白1(PD-1)的表达:深入了解糖皮质激素在抗癌治疗中的最佳应用。
BMC Immunol. 2015 Jun 26;16:39. doi: 10.1186/s12865-015-0103-2.